Loading…
Improving Access to Transfusion Care for Hospice Patients Act of 2023
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,649 other S bills in the 118th — cohort avg 33d
Improving Access to Transfusion Care for Hospice Patients Act of 2023 This bill requires the Center for Medicare and Medicaid Innovation (CMMI) to test a model under which blood transfusions furnished to an individual receiving hospice care are paid separately from the hospice all-inclusive per diem payment under Medicare. The CMMI must evaluate the model by comparing patients participating in the model with those outside of the model in relation to specified metrics, such as hospital utilization and days of hospice care before the end of life.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2024 · fourth_quarter · Medicare/Medicaid
HR 4758 / S 2372, the Accelerating Kids Access to Care Act; HR 5526 / S 3458, the Seniors' Access to Critical Medications Act; HR 8702 / S 4532, Improving Seniors Timely Access to Care Act; HR 1613, the Drug Price Transparency in Medicaid Act; HR 4473, the Medicare Patient Access to Cancer Treatment Act; HR 5378, The Lower Costs, More Transparency Act; HR 7512, the Real-Time Benefit Tool Implementation Act; S 2186, the Improving Access to Transfusion Care for Hospice Patients Act; S 1869, the Site-based Invoicing and Transparency Enhancement (SITE) Act; S 4349, the Electronic Prior Authorization for Prescription Drugs Act Implementation of the Inflation Reduction Act, specifically provisions relating to the Medicare Part D annual and monthly maximum out-of-pocket caps; Proposals to add work requirements to Medicaid programs; Medicaid policies related to the end of certain federal Medicaid maintenance-of-effort requirements; Proposals to promote parity in certain Medicare reimbursement across hospital outpatient and provider office settings;
Read twice and referred to the Committee on Finance.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $180,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2024 · fourth_quarter · Medicare/Medicaid
Coverage of blood transfusions under Medicare Hospice Benefit Issues related to CAR-T/cellular and gene therapies Implementation of the Medicare Access and CHIP Reauthorization Act pf 2015 (P.L. 114-10) Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148) CMS national coverage determinations Medicaid coverage for sickle cell disease Issues related to telemedicine/telehealth Sickle cell disease/trait issues, including coverage for cell and gene therapies Prior authorization Implementation of the Inflation Reduction Act of 2022 (P.L. 117-169) Strengthening Medicare for Patients and Providers Act (H.R. 2474) Resident Physician Shortage Reduction Act (S. 1302) CONNECT for Health Act (S. 2016/ H.R. 4189) Improving Access to Transfusion Care for Hospice Patients Act (S. 2186) Provider Reimbursement Stability Act of 2023 (H.R. 6371) Telehealth Modernization Act (H.R. 7623 / S. 3967) Sickle Cell Disease Comprehensive Care Act (H.R. 7432/S. 5097) dental coverage for Medicare beneficiaries CMS FY 2025 Hospice proposed rule and payment mechanisms for high intensity palliative care services, including blood transfusions Improving Seniors' Timely Access to Care Act (S. 4518/S. 4532/H.R. 8702) Senate Finance Committee Request for Information (RFI) on Medicare physician payment National Coverage Decision for hematopoietic stem cell transplantation (HSCT) for MDS Local Coverage Decisions for hematopoietic stem cell transplantation (HSCT) for lymphoma Duffy-null ICD-10 coding Local Coverage Decisions for next generation sequencing Sickle cell disease quality measures Issues impacting drug shortages Senate draft Pay PCPs Act CY 2025 Hospital Outpatient Prospective Payment System (HOPPS) proposed rule CY 2025 Physician Fee Schedule proposed rule
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · third_quarter · Medicare/Medicaid
HR 4758 / S 2372, the Accelerating Kids Access to Care Act; HR 5526 / S 3458, the Seniors' Access to Critical Medications Act; HR 8702 / S 4532, Improving Seniors Timely Access to Care Act; HR 1613, the Drug Price Transparency in Medicaid Act; HR 4473, the Medicare Patient Access to Cancer Treatment Act; HR 5378, The Lower Costs, More Transparency Act; HR 7512, the Real-Time Benefit Tool Implementation Act; S 2186, the Improving Access to Transfusion Care for Hospice Patients Act; S 1869, the Site-based Invoicing and Transparency Enhancement (SITE) Act; S 4349, the Electronic Prior Authorization for Prescription Drugs Act Implementation of the Inflation Reduction Act, specifically provisions relating to the Medicare Part D annual and monthly maximum out-of-pocket caps; Proposals to add work requirements to Medicaid programs; Medicaid policies related to the end of certain federal Medicaid maintenance-of-effort requirements; Proposals to promote parity in certain Medicare reimbursement across hospital outpatient and provider office settings;
Client expense: $160,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2024 · third_quarter · Medicare/Medicaid
Coverage of blood transfusions under Medicare Hospice Benefit Issues related to CAR-T/cellular and gene therapies Implementation of the Medicare Access and CHIP Reauthorization Act pf 2015 (P.L. 114-10) Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148) CMS national coverage determinations Medicaid coverage for sickle cell disease Issues related to telemedicine/telehealth Sickle cell disease/trait issues, including coverage for cell and gene therapies Prior authorization Implementation of the Inflation Reduction Act of 2022 (P.L. 117-169) Strengthening Medicare for Patients and Providers Act (H.R. 2474) Resident Physician Shortage Reduction Act (S. 1302) CONNECT for Health Act (S. 2016/ H.R. 4189) Improving Access to Transfusion Care for Hospice Patients Act (S. 2186) Provider Reimbursement Stability Act of 2023 (H.R. 6371) Telehealth Modernization Act (H.R. 7623 / S. 3967) Sickle Cell Disease Comprehensive Care Act (H.R. 7432/S. 5097) dental coverage for Medicare beneficiaries CMS FY 2025 Hospice proposed rule and payment mechanisms for high intensity palliative care services, including blood transfusions Improving Seniors' Timely Access to Care Act (S. 4518/S. 4532/H.R. 8702) Senate Finance Committee Request for Information (RFI) on Medicare physician payment National Coverage Decision for hematopoietic stem cell transplantation (HSCT) for MDS Local Coverage Decisions for hematopoietic stem cell transplantation (HSCT) for lymphoma Duffy-null ICD-10 coding Local Coverage Decisions for next generation sequencing Sickle cell disease quality measures Issues impacting drug shortages Senate draft Pay PCPs Act CY 2025 Hospital Outpatient Prospective Payment System (HOPPS) proposed rule CY 2025 Physician Fee Schedule proposed rule
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · second_quarter · Medicare/Medicaid
HR 4758 / S 2372, the Accelerating Kids Access to Care Act; HR 5526 / S 3458, the Seniors' Access to Critical Medications Act; HR 1613, the Drug Price Transparency in Medicaid Act; HR 4473, the Medicare Patient Access to Cancer Treatment Act; HR 5378, The Lower Costs, More Transparency Act; HR 7512, the Real-Time Benefit Tool Implementation Act; S 2186, the Improving Access to Transfusion Care for Hospice Patients Act; S. 1869, the Site-based Invoicing and Transparency Enhancement (SITE) Act Implementation of the Inflation Reduction Act, specifically provisions relating to the Medicare Part D annual and monthly maximum out-of-pocket caps; Proposals to add work requirements to Medicaid programs; Medicaid policies related to the end of certain federal Medicaid maintenance-of-effort requirements; Proposals to promote parity in certain Medicare reimbursement across hospital outpatient and provider office settings;
Client expense: $570,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2024 · second_quarter · Medicare/Medicaid
Coverage of blood transfusions under Medicare Hospice Benefit Issues related to CAR-T/cellular and gene therapies Implementation of the Medicare Access and CHIP Reauthorization Act pf 2015 (P.L. 114-10) Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148) CMS national coverage determinations Medicaid coverage for sickle cell disease Issues impacting opioid access/use for patients with hematologic disease and disorders Issues related to telemedicine/telehealth Sickle cell disease/trait issues, including coverage for cell and gene therapies Sickle Cell Disease Comprehensive Care Act (H.R. 1672/S. 996) Prior authorization Implementation of the Inflation Reduction Act of 2022 (P.L. 117-169) Strengthening Medicare for Patients and Providers Act (H.R. 2474) Resident Physician Shortage Reduction Act (S. 1302) CONNECT for Health Act (S. 2016/ H.R. 4189) Improving Access to Transfusion Care for Hospice Patients Act (S. 2186) Provider Reimbursement Stability Act of 2023 (H.R. 6371) Telehealth Modernization Act (H.R. 7623 / S. 3967) Sickle Cell Disease Comprehensive Care Act (H.R. 7432) dental coverage for Medicare beneficiaries Centers for Medicare & Medicaid Services (CMS) FY 2025 Hospice proposed rule request for information on payment mechanisms for high intensity palliative care services, including blood transfusions Improving Seniors' Timely Access to Care Act (S. 4518/S. 4532/H.R. 8702) Senate Finance Committee Request for Information (RFI) on Medicare Graduate Medical Education (GME) and physician workforce shortages Senate Finance Committee Request for Information (RFI) on Medicare physician payment National Coverage Decision for hematopoietic stem cell transplantation (HSCT) for MDS Local Coverage Decisions for hematopoietic stem cell transplantation (HSCT) for lymphoma Duffy-null ICD-10 coding Issues impacting drug shortages
2024 · first_quarter · Medicare/Medicaid
HR 4758 / S 2372, the Accelerating Kids Access to Care Act; HR 5378, The Lower Costs, More Transparency Act; HR 7512, the Real-Time Benefit Tool Implementation Act; HR 5526 / S 3458, the Seniors' Access to Critical Medications Act; HR 4473, the Medicare Patient Access to Cancer Treatment Act; S 2186, the Improving Access to Transfusion Care for Hospice Patients Act; S. 1869, the Site-based Invoicing and Transparency Enhancement (SITE) Act HR 1613, the Drug Price Transparency in Medicaid Act; Implementation of the Inflation Reduction Act, specifically provisions relating to the Medicare Part D annual and monthly maximum out-of-pocket caps; Proposals to add work requirements to Medicaid programs; Medicaid policies related to the end of certain federal Medicaid maintenance-of-effort requirements; Proposals to promote parity in certain Medicare reimbursement across hospital outpatient and provider office settings;
Client expense: $100,000 · Firm income: Not reported
2024 · first_quarter · Medicare/Medicaid
Coverage of blood transfusions under Medicare Hospice Benefit Issues related to CAR-T/cellular and gene therapies Implementation of the Medicare Access and CHIP Reauthorization Act pf 2015 (P.L. 114-10) Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148) CMS national coverage determinations Medicaid coverage for sickle cell disease Issues impacting opioid access/use for patients with hematologic disease and disorders Issues related to telemedicine/telehealth Sickle cell disease/trait issues, including coverage for cell and gene therapies Sickle Cell Disease Comprehensive Care Act (H.R. 1672/S. 996) Prior authorization Implementation of the Inflation Reduction Act of 2022 (P.L. 117-169) Strengthening Medicare for Patients and Providers Act (H.R. 2474) Resident Physician Shortage Reduction Act (S. 1302) CONNECT for Health Act (S. 2016/ H.R. 4189) Improving Access to Transfusion Care for Hospice Patients Act (S. 2186) Provider Reimbursement Stability Act of 2023 (H.R. 6371) Telehealth Modernization Act (H.R. 7623 / S. 3967) Sickle Cell Disease Comprehensive Care Act (H.R. 7432) National Coverage Decision for hematopoietic stem cell transplantation (HSCT) for MDS dental coverage for Medicare beneficiaries
Client expense: $30,000 · Firm income: Not reported
2023 · fourth_quarter · Medicare/Medicaid
HR 4758 / S 2372, the Accelerating Kids Access to Care Act; HR 3561, the PATIENT Act; HR 3281, the Transparent Price Act; HR 5378, The Lower Costs, More Transparency Act; S 2186, the Improving Access to Transfusion Care for Hospice Patients Act; S. 1869, the Site-based Invoicing and Transparency Enhancement (SITE) Act Implementation of the Inflation Reduction Act, specifically provisions relating to the Medicare Part D annual and monthly maximum out-of-pocket caps; Proposals to add work requirements to Medicaid programs; Medicaid policies related to the end of certain federal Medicaid maintenance-of-effort requirements; Proposals to promote parity in certain Medicare reimbursement across hospital outpatient and provider office settings;
Client expense: $440,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
2023 · fourth_quarter · Medicare/Medicaid
Coverage of blood transfusions under Medicare Hospice Benefit Issues related to CAR-T/cellular and gene therapies Implementation of the Medicare Access and CHIP Reauthorization Act pf 2015 (P.L. 114-10) Implementation of the Patient Protection and Affordable Care Act (P.L. 111-148) CMS national coverage determinations Medicaid coverage for sickle cell disease Issues impacting opioid access/use for patients with hematologic disease and disorders Issues related to telemedicine/telehealth Sickle cell disease/trait issues, including coverage for cell and gene therapies Sickle Cell Disease Comprehensive Care Act (H.R. 1672/S. 996) Prior authorization Implementation of the Inflation Reduction Act of 2022 (P.L. 117-169) Strengthening Medicare for Patients and Providers Act (H.R. 2474) Resident Physician Shortage Reduction Act (S. 1302) CONNECT for Health Act (S. 2016/ H.R. 4189) Improving Access to Transfusion Care for Hospice Patients Act (S. 2186) Provider Reimbursement Stability Act of 2023 (H.R. 6371) Establishment of Disincentives for Health Care Providers That Have Committed Information Blocking proposed rule (RIN 0955-AA05)
Client expense: $30,000 · Firm income: Not reported
2023 · third_quarter · Medicare/Medicaid
HR 4758 / S 2372, the Accelerating Kids Access to Care Act; HR 3561, the PATIENT Act; HR 3281, the Transparent Price Act; HR 5378, The Lower Costs, More Transparency Act; S 2186, the Improving Access to Transfusion Care for Hospice Patients Act; Implementation of the Inflation Reduction Act, specifically provisions relating to the Medicare Part D annual and monthly maximum out-of-pocket caps; Proposals to add work requirements to Medicaid programs; Medicaid policies related to the end of certain federal Medicaid maintenance-of-effort requirements; Clarifying Medicare coverage for certain medically-necessary dental services; Proposals to promote parity in certain Medicare reimbursement across hospital outpatient and provider office settings;
Client expense: $150,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE